| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1378e4e816657f095df9b6d90dc46019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4a76893c6151e8010297791208ebb83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fe89e6c28df60159d0394bca0df5d82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8c6b9fc951438e606a7e98479db699f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6d8b67c84216dbc2472a7176c50a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3814ff09724b0b9cdc5c864a965d84f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcdaf2447167a90969efd7156166cf00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c6215e723ef47693b943b0e84c02be |
| publicationDate |
2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3322687-B1 |
| titleOfInvention |
2-benzyl-indanone compounds as anticancer agent and a process for preparation thereof |
| priorityDate |
2015-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |